BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 7 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 7 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 7 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 8 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 8 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 9 hours ago Atmus Welcomes Heath Sharp to Board of Directors 11 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 11 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 7 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 7 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 7 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 8 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 8 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 9 hours ago Atmus Welcomes Heath Sharp to Board of Directors 11 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 11 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago
ADVERTISEMENT
Market News

Biocept Inc (BIOC) Q4 2020 Earnings Call

Biocept Inc (NASDAQ: BIOC) Q4 2020 earnings call dated Mar. 29, 2021. Corporate Participants: Jody Cain — Investor Relations Michael W. Nall — President and Chief Executive Officer Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director Analysts: Michael Okunewitch — Maxim Group — Analyst _________ To read the […]

$BIOC April 1, 2021 1 min read

Biocept Inc (NASDAQ: BIOC) Q4 2020 earnings call dated Mar. 29, 2021.

Corporate Participants:

Jody Cain — Investor Relations

Michael W. Nall — President and Chief Executive Officer

Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations

Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director

ADVERTISEMENT

Analysts:

Michael Okunewitch — Maxim Group — Analyst

_________

To read the full earnings call transcript, click here

ADVERTISEMENT